Geode Capital Management
ORMP icon

Geode Capital Management’s Oramed Pharmaceuticals ORMP Stock Holding History

Geode Capital Management’s Portfolio ORMP Stock Details ORMP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$82.6K Hold
24,282
– – ﹤0.01% 4177
2025
Q4 		$69.2K Hold
24,282
– – ﹤0.01% 4175
2025
Q3 		$64.1K Hold
24,282
– – ﹤0.01% 4237
2025
Q2 		$54.6K Sell
24,282
-1,173
-5% -$2.59K ﹤0.01% 4198
2025
Q1 		$54.5K Hold
25,455
– – ﹤0.01% 4182
2024
Q4 		$61.6K Hold
25,455
– – ﹤0.01% 4207
2024
Q3 		$62.1K Hold
25,455
– – ﹤0.01% 4219
2024
Q2 		$65.4K Hold
25,455
– – ﹤0.01% 4230
2024
Q1 		$74.3K Hold
25,455
– – ﹤0.01% 4240
2023
Q4 		$58.8K Buy
25,455
+4,546
+22% +$9.71K ﹤0.01% 4311
2023
Q3 		$54.6K Hold
20,909
– – ﹤0.01% 4401
2023
Q2 		$74.9K Buy
20,909
+2,779
+15% +$8.91K ﹤0.01% 4419
2023
Q1 		$39.5K Hold
18,130
– – ﹤0.01% 4568
2022
Q4 		$218K Hold
18,130
– – ﹤0.01% 4050
2022
Q3 		$117K Hold
18,130
– – ﹤0.01% 4499
2022
Q2 		$83K Sell
18,130
-303,029
-94% -$1.62M ﹤0.01% 4651
2022
Q1 		$2.78M Buy
321,159
+75,814
+31% +$777K ﹤0.01% 3086
2021
Q4 		$3.5M Sell
245,345
-1,626
-0.7% -$34K ﹤0.01% 3086
2021
Q3 		$5.43M Buy
246,971
+29,263
+13% +$498K ﹤0.01% 2862
2021
Q2 		$2.91M Buy
217,708
+200,751
+1,184% +$2.3M ﹤0.01% 3154
2021
Q1 		$172K Hold
16,957
– – ﹤0.01% 4161
2020
Q4 		$71K Hold
16,957
– – ﹤0.01% 4114
2020
Q3 		$44K Hold
16,957
– – ﹤0.01% 4036
2020
Q2 		$59K Hold
16,957
– – ﹤0.01% 3953
2020
Q1 		$51K Hold
16,957
– – ﹤0.01% 3920
2019
Q4 		$87K Hold
16,957
– – ﹤0.01% 3990
2019
Q3 		$54K Hold
16,957
– – ﹤0.01% 4054
2019
Q2 		$60K Buy
+16,957
New +$59.8K ﹤0.01% 4059

Other funds holding ORMP

BCM
BML Capital Management Zionsville, Indiana $156M AUM 129.82% 1-Year Est. Return
AF
Aquamarine Financial George Town $1.37B AUM
Mercer Global Advisors
Mercer Global Advisors Denver, Colorado $67.6B AUM 18.3% 1-Year Est. Return
GIA
Gem Investment Advisors Teaneck, New Jersey $102M AUM
M
Murchinson Toronto, Ontario, Canada $791M AUM 68.08% 1-Year Est. Return
BFM
Boothbay Fund Management New York $7.71B AUM 106.31% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
RG
Rathbones Group Liverpool, United Kingdom $25B AUM 18.87% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Geode Capital Management's ORMP Position: Q1 2026 in Review

Geode Capital Management held its Oramed Pharmaceuticals (ORMP) position steady in Q1 2026 at 24,282 shares worth $82.6K. The position accounts for ﹤0.01% of the portfolio, ranked #4177.

Geode Capital Management first reported a position in ORMP in Q2 2019 and has held it in 28 quarters since. The position peaked at $5.43M in Q3 2021. 64 funds tracked by Wall St. Rank hold ORMP as of Q1 2026.

  • Geode Capital Management held 24,282 shares of Oramed Pharmaceuticals worth $82.6K as of Q1 2026.
  • Geode Capital Management left its Oramed Pharmaceuticals share count unchanged in Q1 2026.
  • Oramed Pharmaceuticals made up ﹤0.01% of Geode Capital Management's portfolio in Q1 2026, its #4177 holding.
  • Geode Capital Management first reported a position in Oramed Pharmaceuticals in Q2 2019 and has held it in 28 quarters since.
  • Geode Capital Management's Oramed Pharmaceuticals position peaked at $5.43M in Q3 2021.
  • 64 funds tracked by Wall St. Rank held Oramed Pharmaceuticals as of Q1 2026.

Based on Geode Capital Management's 13F filing for Q1 2026, filed 15 May 2026.